Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells

article OA: closed CC0 ⤵ 84 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
AI-generated summary by claude@2026-06, 2026-06-07

Dienogest was found to inhibit BrdU uptake and induce G0/G1 cell cycle arrest in cultured endometriotic stromal cells.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Bromodeoxyuridine Cell Proliferation Endometriosis G1 Phase Nandrolone Ovarian Diseases Resting Phase, Cell Cycle Stromal Cells Adult Bromodeoxyuridine Cell Cycle Cell Cycle Cell Proliferation Cells, Cultured Contraceptives, Oral Contraceptives, Oral DNA DNA Drug Evaluation, Preclinical Endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (32)

Cited by (50)

Source provenance

europepmc
last seen: 2026-06-11T06:19:48.454388+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:15:00.519696+00:00
License: CC0 · commercial use OK